| http://www.w3.org/ns/prov#value | - d of such a stabilization comprising the controlled delivery from any catheter-based device, intraluminal medical device or adventitial medical device of a therapeutically effective amount of rapamycin or a rapamycin derivative having mTOR inhibiting properties, optionally in conjunction with one or more other active co-agents, e.g. as disclosed above. [0055] 1.5 A method as defined in 1.1 to 1.4
|
